EuroSIDA Publications 2015

1 Efficacy of etravirine combined with darunavir or other ritonavir-boosted protease inhibitors in HIV-1-infected patients: an observational study using pooled European cohort data. J Vingerhoets, V Calvez, P Flandre, AG Marcelin, F Ceccherini-Silberstein, CF Perno, MM Santoro, R Bateson, M Nelson, A Cozzi-Lepri, J Grarup, J Lundgren, F Incardona, R Kaiser, A Sonnerborg, B Clotet, R Paredes, HF Günthard, B Ledergerber, A Hoogstoel, S Nijs, L Tambuyzer, L Lavreys, M Opsomer on behalf of The Etravirine Cohort Study Group.
HIV Med. 2015 May;16(5):297-306. doi: 10.1111/hiv.12218. abstract

2 Impact of body weight on virological and immunological responses to efavirenz-containing regimens in HIV-infected, treatment-naive adults. 
C Marzolinia, C Sabin, F Raffi, M Siccardid, C Mussini, O Launay, D Burger, B Roca, J Fehr, S Bonora, A Mocroft, N Obel, F-A Dauchy, R Zangerle, C Gogos, N Gianotti, A Ammassari, C Torti, J Ghosn, G Chene, J Grarup, M Battegay, for the Efavirenz, Obesity Project Team on behalf of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord.
AIDS. 2015 Jan 14;29(2):193-200 abstract

3 Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients. The Antiretroviral Therapy Cohort Collaboration (ART-CC). AIDS 2015;29:373-383. abstract

4 Hepatitis C seroconversions in HIV infection across Europe: which regions and patient groups are affected? C. Boesecke, D. Grint, V. Soriano, J.D. Lundgren, A. d'Arminio Monforte, V.M. Mitsura, N. Chentsova, V. Hadziosmanovic, O. Kirk, A. Mocroft, L. Peters, J. Rockstroh for EuroSIDA in EuroCoord.
Liver Int. 2015 Nov;35(11):2384-91. doi: 10.1111/liv.12848. Epub 2015 Apr 29. (IF: 4.41) abstract

5 Cancer Risk and Use of Protease Inhibitor or Nonnucleoside Reverse Transcriptase Inhibitor-Based Combination Antiretroviral Therapy: The D: A: D Study. Bruyand M, Ryom L, Shepherd L, Fatkenheuer G, Grulich A, Reiss P, de Wit S, D Arminio Monforte A, Furrer H, Pradier C, Lundgren J, Sabin C; D:A:D study group.
J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):568-577. 

6 Development and validation of a risk-score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study. A Mocroft, JD Lundgren, M Ross, M Law, P Reiss, O Kirk, C Smith, D Wentworth, J Neuhaus, CA Fux, O Moranne, P Morlat, MA Johnson, L Ryom on behalf of the Data on Adverse Events (D:A:D) study group, the Royal Free Hospital Clinic Cohort and the INSIGHT, SMART and ESPRIT study group.
PlOS Medicine 2015 Mar 31; 12 (3). 

7 Major differences in organisation and availability of health care and medicines for HIV/TB coinfected patients across Europe. Mansfeld M, Skrahina A, Shepherd L, Schultze A, Panteleev AM, Miller RF, Miro JM, Zeltina I, Tetradov S, Furrer H, Kirk O, Grzeszczuk A, Bolokadze N, Matteelli A, Post FA, Lundgren JD, Mocroft A, Efsen A, Podlekareva DN for the TB:HIV study group in EuroCoord. 
HIV Med. 2015 Oct;16(9):544-52. doi: 10.1111/hiv.12256.  (IF: 3.454)  abstract

8 Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA cohort. D. Podlekareva, D Grint, I. Karpov, A. Rakmanova, K Mansinho, N. Chentsova, I. Zeltina, M. Losso, M. Parczewski J. D. Lundgren, A. Mocroft, O. Kirk for EuroSIDA in EuroCoord.
HIV Med. 2015 May 18. doi: 10.1111/hiv.12254 [Epub ahead of print] 

9 HIV resistance testing and detected drug resistance in Europe: Data from the EuroSIDA cohort 1997-2012. A Schultze, AN Phillips, R Paredes, M Battegay, JK Rockstroh, L Machala, J Tomazic, I Januskevica, PM Girard, K Laut, JD Lundgren, A Cozzi-Lepri. 
AIDS. 2015 Jul 17, 29(11): 1379-89. 

10 Liver-related death among HIV/HCV coinfected individuals, implications for the era of directly acting antivirals. 
D Grint, L Peters, JK Rockstroh, A Rakmanova, T Trofimova, K Lacombe, I Karpov, M Galli, P Domingo, O Kirk, JD Lundgren, A. Mocroft for EuroSIDA in EuroCoord.
AIDS. 2015 Jun 19;29(10):1205-15. doi: 10.1097/QAD.0000000000000674. (IF: 6.348) abstract

11 Major challenges in clinical management of TB/HIV coinfected patients in Eastern Europe compared with Western Europe and Latin America. Anne Marie W. Efsen, Anna Schultze, Frank A. Post, Alexander Panteleev, Hansjakob Furrer, Robert F. Miller, Marcelo H. Losso, Javier Toibaro, Aliaksandr Skrahin, Jose M. Miro, Joan A. Caylà, Enrico Girardi, Mathias Bruyand, Niels Obel, Daria N. Podlekareva, Jens D. Lundgren, Amanda Mocroft, Ole Kirk on behalf of the TB:HIV study group in EuroCoord.
PLoS One. 2015 Dec 30;10(12):e0145380. doi: 10.1371/journal.pone.0145380. eCollection 2015. article

12 Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study, 2010 to 2013. The Late Presenters Working Group for COHERE in EuroCoord. 
Euro Surveill. 2015 Nov;20(47). abstract

13 Mortality in migrants living with HIV in western Europe (1997-2013): a collaborative cohort study. Migrants Working Group on behalf of COHERE in EuroCoord. 
Lancet HIV. 2015 Dec;2(12):e540-9. abstract

Total publications December 2015: 231

In Press